| 1 |
34412518 | Angiotensin-converting enzyme inhibitor induced angioedema: not always a class effect? A case report and short narrative review. | 2021 Nov |
1 |
| 2 |
32416091 | iTRAQ-based proteomics and in vitro experiments reveals essential roles of ACE and AP-N in the renin-angiotensin system-mediated congenital ureteropelvic junction obstruction. | 2020 Aug 1 |
2 |
| 3 |
25680080 | The implications of angiotensin-converting enzymes and their modulators in neurodegenerative disorders: current and future perspectives. | 2015 Apr 15 |
1 |
| 4 |
24986000 | [Comparison of American and European (Czech) guidelines for diagnosis and treatment of chronic heart failure]. | 2014 Apr |
1 |
| 5 |
24285767 | Angiotensin-converting enzyme inhibitors for intermittent claudication associated with peripheral arterial disease. | 2013 Nov |
1 |
| 6 |
24250503 | Lipophilicity Examination of Some ACE inhibitors andHydrochlorothiazide on Cellulose in RP Thin-Layer Chromatography. | 2012 Summer |
1 |
| 7 |
21496825 | Ultra-thin-layer chromatography mass spectrometry and thin-layer chromatography mass spectrometry of single peptides of angiotensin-converting enzyme inhibitors. | 2011 May 20 |
1 |
| 8 |
20634797 | Effects of ACE inhibitors on cardiac angiotensin II and aldosterone in humans: "Relevance of lipophilicity and affinity for ACE". | 2010 Nov |
4 |
| 9 |
19334497 | [Combined antihypertensive treatment of patients with hypertension and type 2 diabetes mellitus]. | 2009 |
1 |
| 10 |
17404826 | Anti-inflammatory actions of quinapril. | 2007 Jun |
1 |
| 11 |
17917517 | The role of quinapril in the presence of a weight loss regimen: endothelial function and markers of obesity in patients with the metabolic syndrome. | 2007 Fall |
1 |
| 12 |
17928625 | Comparison of selective AT1-receptor blockade versus ACE inhibition for restenosis prophylaxis in patients with peripheral occlusive arterial disease after stent angioplasty: a randomized, controlled, proof-of-concept study. | 2007 Dec-2008 Jan |
1 |
| 13 |
16487914 | Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism. | 2006 Mar |
1 |
| 14 |
16765977 | Interaction of quinapril anion with cationic surfactant micelles of cetyltrimethylammonium bromide. | 2006 Sep 15 |
2 |
| 15 |
16781228 | Angiotensin-converting enzyme inhibition in patients with coronary artery disease and preserved left ventricular function Ischemia Management with Accupril post-bypass graft via inhibition of angiotensin-converting enzyme (IMAGINE) compared with the other major trials in coronary artery disease. | 2006 Jun |
2 |
| 16 |
17205927 | Auto-intoxication with flecainide and quinapril: ECG-changes, symptoms and treatment. | 2006 Dec |
1 |
| 17 |
15353612 | The non-thiol angiotensin-converting enzyme inhibitor quinapril suppresses inflammatory arthritis. | 2005 Jan |
2 |
| 18 |
16191467 | The development and stability assessment of extemporaneous pediatric formulations of Accupril. | 2005 Nov 4 |
2 |
| 19 |
16265685 | Effects of Angiotensin-converting enzyme inhibition and statin treatment on inflammatory markers and endothelial functions in patients with longterm rheumatoid arthritis. | 2005 Nov |
1 |
| 20 |
14984622 | If it is not cough, it must be dysgeusia: differing adverse effects of angiotensin-converting enzyme inhibitors in the same individual. | 2004 Mar-Apr |
1 |
| 21 |
15117912 | Determinants of blood pressure response to quinapril in black and white hypertensive patients: the Quinapril Titration Interval Management Evaluation trial. | 2004 Jun |
1 |
| 22 |
15220251 | Quinapril, an ACE inhibitor, reduces markers of oxidative stress in the metabolic syndrome. | 2004 Jul |
4 |
| 23 |
15342298 | Comparison of effects of quinapril versus enalapril on vasoactive substances following acute myocardial infarction. | 2004 Sep 1 |
1 |
| 24 |
15526248 | Vascular effects of quinapril completely depend on ACE insertion/deletion polymorphism. | 2004 Sep |
2 |
| 25 |
12616664 | Pharmacokinetics of quinapril in children: assessment during substitution for chronic angiotensin-converting enzyme inhibitor treatment. | 2003 Feb |
1 |
| 26 |
12652958 | [Angiotensin-converting enzyme, quinapril, in treating chronic cardiac failure]. | 2003 |
1 |
| 27 |
12808303 | Elimination kinetics of quinaprilat and perindoprilat in hypertensive patients with renal failure on haemodialysis. | 2003 Jun |
2 |
| 28 |
12975595 | The effect of quinapril on functional status of elderly patients with diastolic heart failure. | 2003 Mar |
1 |
| 29 |
14680725 | Effects of angiotensin-converting enzyme inhibition on transient ischemia: the Quinapril Anti-Ischemia and Symptoms of Angina Reduction (QUASAR) trial. | 2003 Dec 17 |
1 |
| 30 |
14728069 | ACE Inhibition with moexipril: a review of potential effects beyond blood pressure control. | 2003 |
1 |
| 31 |
11817979 | Quinapril: a further update of its pharmacology and therapeutic use in cardiovascular disorders. | 2002 |
5 |
| 32 |
11849656 | Influence of angiotensinogen M253T gene polymorphism and an angiotensin converting enzyme inhibitor on restenosis after percutaneous coronary intervention. | 2002 Feb |
1 |
| 33 |
11986905 | Blockade of endothelial enzymes: new therapeutic targets. | 2002 Mar |
2 |
| 34 |
12149661 | Circulating intercellular cell adhesion molecule-1, endothelin-1 and von Willebrand factor-markers of endothelial dysfunction in uncomplicated essential hypertension: the effect of treatment with ACE inhibitors. | 2002 Aug |
1 |
| 35 |
12464983 | Ischemia Management with Accupril post bypass Graft via Inhibition of angiotensin coNverting enzyme (IMAGINE): a multicentre randomized trial - design and rationale. | 2002 Nov |
3 |
| 36 |
11204290 | Quinapril treatment enhances vascular sensitivity to insulin. | 2001 Jan |
1 |
| 37 |
11208485 | Significance of endothelial prostacyclin and nitric oxide in peripheral and pulmonary circulation. | 2001 Jan-Feb |
1 |
| 38 |
11230836 | Effects of quinapril on clinical outcome after coronary artery bypass grafting (The QUO VADIS Study). QUinapril on Vascular Ace and Determinants of Ischemia. | 2001 Mar 1 |
1 |
| 39 |
11325479 | Chemical reactivity in solid-state pharmaceuticals: formulation implications. | 2001 May 16 |
2 |
| 40 |
11487379 | A single (investigator)-blind randomised control trial comparing the effects of quinapril and nifedipine on platelet function in patients with mild to moderate hypertension. | 2001 Aug |
2 |
| 41 |
11800416 | Quinapril with high affinity to tissue angiotensin-converting enzyme reduces restenosis after percutaneous transcatheter coronary intervention. | 2001 Jul |
3 |
| 42 |
10636260 | Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study) | 2000 Jan |
2 |
| 43 |
10755201 | Angiotensin II formation in human vasculature after chronic ACE inhibition: a prospective, randomized, placebo-controlled study. QUO VADIS Investigators. | 2000 Feb |
1 |
| 44 |
10784227 | Angiotensin-converting enzyme inhibition by quinapril blocks the albuminuric effect of atrial natriuretic peptide in Type 1 diabetes and microalbuminuria. | 2000 Mar |
1 |
| 45 |
10906624 | Clinical data: AVERT and QUO VADIS. | 2000 Aug |
6 |
| 46 |
11190581 | [Does quinapril improve coronary vasoconstriction in vasospastic angina?]. | 2000 Dec |
3 |
| 47 |
11967824 | Acute effects of ACE inhibition on coronary endothelial dysfunction. | 2000 Dec |
2 |
| 48 |
23315349 | Efficacy and Safety of Quinapril 40mg Once Daily as Monotherapy for Patients with Poorly Controlled Hypertension : The EUREKA Study. | 2000 |
1 |
| 49 |
10072217 | Mechanism by which quinapril improves vascular function in coronary artery disease. | 1999 Feb 1 |
1 |
| 50 |
10082500 | ACE inhibitor versus beta-blocker for the treatment of hypertension in renal allograft recipients. | 1999 Mar |
1 |